NCT05616767

Brief Summary

The long-term objective of the parent study is "to reduce the effects of OPCa through secondary prevention (i.e., early detection, diagnosis and treatment referral)." Consistent with this, this supplement will test HPV-related interventions tailored for Sexual Minority Men (SMM). Acceptability, feasibility and preliminary effectiveness of a smart-phone delivered Oropharyngeal Cancer (OPCA) self-assessment tool will be assessed. Given that homosexuality is stigmatized and criminalized in Tanzania, and that cell phone use is the key way SMM communicate in Tanzania, a self-assessment screening cell phone intervention holds particular promise for SMM in Tanzania but warrants separate evaluation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 15, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

November 30, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2023

Completed
Last Updated

December 14, 2023

Status Verified

December 1, 2023

Enrollment Period

5 months

First QC Date

October 28, 2022

Last Update Submit

December 13, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • assess screening practices of hrHPV-related OPCa

    Questionaire

    Baseline

  • To assess the acceptability and feasibility of teaching SMM in Tanzania to conduct self-exams

    Questionaire to assess post-test selfie evaluations, Scores: 0= was not trained; 1= was trained; 2=took a selfie; 3= clear selfie

    baseline to 6 months

  • To assess the acceptability and feasibility of hrHPV vaccination

    percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination

    baseline

  • To assess the acceptability and feasibility of hrHPV vaccination

    percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination

    1 month

  • To assess the acceptability and feasibility of hrHPV vaccination

    percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination

    6 months

Study Arms (1)

Training on self-screening and HPV vaccination administration

EXPERIMENTAL

teaching SMM in Tanzania to conduct self-exams for oropharyngeal hrHPV-associated cancers using cellphone-mediated oral selfies, and administering the HPV vaccination series (with 2 and 6-8 month follow-up) to those who request it

Other: Training on self-screening and HPV vaccination administration

Interventions

Participants will be taught how to do self-screening for HPV-associated cancers using Training on self-screening and HPV vaccination administration. They will also be given HPV vaccination series.

Training on self-screening and HPV vaccination administration

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsgay or bisexual men
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18
  • gay or bisexual men
  • speak Kiswahili or English
  • resident in Dar es Salam

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dar es Salaam

Dar es Salaam, Tanzania

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2022

First Posted

November 15, 2022

Study Start

November 30, 2022

Primary Completion

April 25, 2023

Study Completion

April 25, 2023

Last Updated

December 14, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations